Diabetes Mellitus Non-Insulin Medications Learning Activity

12345678
Across
  1. 4. This medication class promotes insulin release and is only used in type 2 diabetes. The major side effects of this medication are weight gain and hypoglycemia.
  2. 5. This medication class reduces the reabsorption of glucose by the kidneys and increases urinary glucose excretion. Hypoglycemia risk is low and common side effects include weight loss and decreased blood pressure. This medication is commonly used to treat patients with heart failure as well as diabetes.
  3. 6. This medication class decreases insulin resistance. The hypoglycemia risk is low but patients should be monitored for fluid retention and should be used with caution in patients who have heart failure.
  4. 7. This medication class inhibits glucose production in the liver, sensitizes insulin receptors in fat and skeletal muscle to increase glucose uptake, and reduces glucose absorption in the gut. Low risk of hypoglycemia.
  5. 8. This class of medication enhances the action of incretin hormones. Hypoglycemia risk is low.
Down
  1. 1. This class of medication is a non-insulin injectable used to treat type 2 diabetes. It slows gastric emptying, stimulates glucose-dependent insulin release, inhibits postprandial glucagon release, and suppresses appetite. Hypoglycemia risk is low and this medication may also be used for weight loss.
  2. 2. This medication class acts in the intestine to delay carbohydrate absorption. This medication class is not often used in the United States due to its side effects of flatulence and borborygmus. Hypoglycemia risk is low when used alone but increases if used with sulfonylurea or insulin.
  3. 3. This medication class stimulates pancreatic insulin release, is short-acting, and taken with each meal. If not taken with meals, this class of medication has a high hypoglycemia risk.